Close Menu

NEW YORK – Three decentralized tests for SARS-CoV-2, the virus that causes COVID-19, have been granted Emergency Use Authorization from the US Food and Drug Administration in the past 10 days. But whether deploying testing closer to patients will fundamentally change how the ongoing outbreak ultimately plays out may hinge on how many tests can be quickly deployed and how clinically accurate they prove to be.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.